MEPSGEN visited Bio Japan 2023 and was able to accomplish great success.

MEPSGEN, a leading biotechnology start-up company, recently participated in the shared booth at Bio Japan 2023 in Yokohama, Japan from Oct 11th – Oct 13th. 

This was the company's first time exhibiting at the event, and it was a great opportunity to showcase its innovative technologies and meet with potential partners and investors.

Bio Japan is one of the largest and most important biotechnology events not only in Asia but also in the world.

It brought together thousands of companies, researchers, and investors from all over the globe.

This year's event was the biggest Bio Japan ever with 16,138 people attending the exhibition.

MEPSGEN was one of many companies that participated in the shared booth organized by the Korea Institute of Toxicology (KITOX). 

This was a great opportunity for the start-up companies to get exposure to a large audience of potential partners and investors.

Hence, MEPSGEN was well-received, and it generated a lot of interest from attendees.

During the three-day event, the MEPSGEN team also visited other booths to introduce ourselves and explore potential collaboration opportunities.

We were pleasantly surprised and grateful for the warm welcome we received from the other participants.

MEPSGEN also had the opportunity to meet with some big pharmaceutical companies at Bio Japan like Takeda, Roche, MSD, etc. 

These meetings were very productive, and we hope that they could lead to new partnerships and collaborations in the future.

Overall, MEPSGEN's participation in Bio Japan was a great success.

The company was able to showcase its innovative technologies, meet with potential partners and investors, and generate a lot of interest in its products and services.

MEPSGEN is very pleased with the results of its participation in Bio Japan and was very pleased to see familiar faces as well.

The company is confident that this event will help to further its growth and success in the biotechnology industry.